APA (7th ed.) Citation

Andrikopoulou, A., Zagouri, F., Goula, K., Haidopoulos, D., Thomakos, N., Svarna, A., . . . Liontos, M. Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies. BMC.

Chicago Style (17th ed.) Citation

Andrikopoulou, Angeliki, Flora Zagouri, Kallirroi Goula, Dimitrios Haidopoulos, Nikolaos Thomakos, Anna Svarna, Meletios-Athanasios Dimopoulos, and Michalis Liontos. Real-world Evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing Gynecological Malignancies. BMC.

MLA (9th ed.) Citation

Andrikopoulou, Angeliki, et al. Real-world Evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing Gynecological Malignancies. BMC.